- Home
- DRRX
DRRX
DURECT Corporation
as 11-15-2024 4:00pm EST
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | CUPERTINO |
| Market Cap: | 44.4M | IPO Year: | 2000 |
| Target Price: | $5.00 | AVG Volume (30 days): | 68.2K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.67 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.48 - $1.88 | Next Earning Date: | 11-13-2024 |
| Revenue: | $8,594,000 | Revenue Growth: | -6.53% |
| Revenue Growth (this year): | -4.08% | Revenue Growth (next year): | 3.07% |
Latest DURECT Corporation News
DRRX Breaking Stock News: Dive into DRRX Ticker-Specific Updates for Smart Investing
Thomson Reuters StreetEvents
3 days ago
Q3 2024 DURECT Corp Earnings Call
GuruFocus.com
3 days ago
Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Cost Reductions and ...
Zacks
4 days ago
Durect (DRRX) Reports Q3 Loss, Misses Revenue Estimates
Associated Press Finance
4 days ago
Durect: Q3 Earnings Snapshot
PR Newswire
4 days ago
DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update
PR Newswire
11 days ago
DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update
PR Newswire
a month ago
DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024
GuruFocus.com
a month ago
Durect Corp (DRRX) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Advances Amid ...
Compare DRRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DRRX DURECT Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.